Möchten Sie immer auf dem neuesten Stand bleiben?

In a high-stakes, time-sensitive transaction highlighting both urgency and opportunity in today’s real estate market, Crown Guard Capital LLC has success

AGOURA HILLS, Calif., March 23, 2026 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (OTCQB:OTLC) ("Oncotelic", the "Company" or "We" or “Our”), a leader in RNA-based therapeutics, announced today...

Allschwil, Switzerland, March 23, 2026 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial...

NEW YORK, March 20, 2026 (GLOBE NEWSWIRE) -- Genco Shipping & Trading Limited (NYSE:GNK) (“Genco” or the “Company”), the largest U.S. headquartered drybulk shipowner focused on the global...

NEW YORK, March 20, 2026 (GLOBE NEWSWIRE) -- Security IP is entering a new phase of accelerated growth as OEMs push for fully integrated, certification‑ready security components across semiconductor...

Cosmos Health Provides Update; Evaluates Options to Address Valuation Disconnect; Will Issue Updated Guidance Following FY 2025 Results

Proposal Substantially Undervalues Genco, Fails to Provide an Appropriate Premium and Presents Execution Risks “Fire Sale” of 16 Genco Vessels to a Competitor Highlights Diana’s Undervalued Proposal...

Highly comparable biodistribution profiles of Radio-DARPin candidates labeled with imaging isotopes 177Lu or 203Pb allows for rapid expansion of pipeline with multiple therapeutic isotopes ...

PRESS RELEASE        Paris, 18 March 2026 – 5:45pm YOUR OPERATIONAL LEASING SOLUTION FOR SUSTAINABLE TRANSPORTATION 2025 RESULTS Positive net income in an unstable geopolitical and economic...

The 7 mg dose of OV329 demonstrated favorable safety and tolerability profile, reinforcing best-in-category potential for refractory epilepsies; Ovid advancing plans to initiate a Phase 2 trial in...